For roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt and ...

The following is a summary of “Recognition of glycine versus non-glycine citrulline motifs dictates the HLA class II ...

Coeliac disease is an autoimmune condition where the body attacks ... Having certain gene markers, namely HLA-DQ2 or HLA-DQ8, can also increase your risk of developing the condition.

What we know about coeliac disease – as Rebecca Adlington shares diagnosis - It’s estimated that 1 in 100 people have it; ...

Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term ...

Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically ...

These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These ...